BioSpace News Archive

Myovant Sciences announced financial results for the first quarter of fiscal year 2022 and provided other corporate updates.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), today announced its financial results for the second quarter and six months ended June 30, 2022, and provided an update on its clinical pipeline and other corporate developments.

Accuray Incorporated will report financial results for the fourth quarter and fiscal year 2022, ended June 30, 2022, after the market close on August 10, 2022.

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report second quarter financial results on Wednesday, August 3, 2022, at 8:30 a.m. ET.

CooperCompanies announced it will release third quarter 2022 financial results on Wednesday, August 31, 2022, at 4:15 PM ET.

DURECT Corporation announced that it will report its first quarter 2022 financial results and host a conference call after the market close on Thursday, August 4, 2022.

Apyx Medical Corporation, the manufacturer of proprietary helium plasma and radiofrequency technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced its first reporting of environmental, social and governance data via a newly released tear sheet.

Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced that it will release its second quarter 2022 financial results before market open on Friday, August 5, 2022.

CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2022.

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will present at the Canaccord Genuity 42nd Annual Growth Conference.